Guest guest Posted July 14, 2002 Report Share Posted July 14, 2002 Hi Jan, First, I thank you for your comments on the research I post. As a Moderator, I certainly appreciate hearing positive feedback! At this point, I do not have further NT-3 information for you. Since people with other demyelinating neuropathies, such as CIDP, Guillian Barre and Mag could also benefit, I am certain Dr. Sahenk is doing great to get the current project concluded by fall, knowing many people are waiting. Usually with human subjects in a trial, there are 3 stages in months and sometimes these can spread out over a few years. Then I am thinking the FDA needs to give their approval, but stick around - I will ask Dr. Sahenk your questions too - who knows, maybe some members from our group would like to participate in the human trials? ~ Gretchen Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.